Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: Comparison of normal and abnormal human tissues

American Journal of Pathology

Volumn 150, Issue 4, 1997, Pages 1443-1455

  Friedl, Andreas ^a,b   Chang, Zhen ^a   Tierney, Adam ^a   Rapraeger, Alan C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; GROWTH REGULATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SUBENDOTHELIUM; TISSUE INDUCTION;

3T3 CELLS; ANIMALS; BASEMENT MEMBRANE; CARCINOMA, RENAL CELL; EPIDERMIS; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HEPARITIN SULFATE; HUMANS; KIDNEY NEOPLASMS; KIDNEY TUBULES; MICE; PROTEIN BINDING; SKIN;

EID: 0030895268     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Klagsbrun M: The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1989, 1:207-235
2. Mason IJ: The ins and outs of fibroblast growth factors. Cell 1994, 78:547-552
3. Johnson DE, Williams LT: Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993, 60:1-41
4. Kan M, Wang F, Xu J, Crabb JW, Hou J, McKeehan WL: An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 1993, 1918, 259:1918-1921
5. Mohammadi M, Dikic I, Sorokin A, Burgess WH, Jaye M, Schlessinger J: Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol Cell Biol 1996, 16: 977-989
6. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I: Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 1994, 79:1015-1024
7. Jaye M, Schlessinger J, Dionne CA: Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1992, 1135:185-199
8. Werner S, Duan DS, de Vries C, Peters KG, Johnson DE, Williams LT: Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 1992, 12:82-88
9. Rapraeger AC, Krufka A, Olwin BB: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252:1705-1708
10. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P: Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 1992, 12: 240-247
11. Ruoslahti E: Structure and biology of proteoglycans. Annu Rev Cell Biol 1988, 4:229-255
12. Aaronson SA, Bottaro DP, Miki T, Ron D, Finch PW, Fleming TP, Ahn J, Taylor WG, Rubin JS: Keratinocyte growth factor: a fibroblast growth factor family member with unusual target cell specificity. Ann NY Acad Sci 1991, 638:62-77
13. Mathieu M, Chatelain E, Ornitz D, Bresnick J, Mason I, Kiefer P, Dickson C: Receptor binding and mitogenic properties of mouse fibroblast growth factor 3: modulation of response by heparin. J Biol Chem 1995, 270: 24197-24203
14. Reich-Slotky R, Bonneh-Barkay D, Shaoul E, Bluma B, Svahn CM, Ron D: Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor. J Biol Chem 1994, 269:32279-32285
15. Moscatelli D: High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 1987, 131:123-130
16. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H: Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992, 119:961-975
17. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
18. Schulze-Osthoff K, Risau W, Vollmer E, Sorg C: in situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 1990, 137:85-92
19. Hughes SE, Hall PA: Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest 1993, 69:173-182
20. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z: Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990, 63: 832-840
21. Reed JA, Albino AP, McNutt NS: Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995, 72:215-222
22. Koji T, Chedid M, Rubin JS, Slayden OD, Csaky KG, Aaronson SA, Brenner RM: Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin. J Cell Biol 1994, 125:393-401
23. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR: Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 1994, 91:1074-1078
24. Ulich TR, Yi ES, Cardiff R, Yin S, Bikhazi N, Biltz R, Morris CF, Pierce GF: Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor. Am J Pathol 1994, 144:862-868
25. Hines MD, Allen-Hoffmann BL: Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes. J Biol Chem 1996, 271:6245-6251
26. Quo L, Yu QC, Fuchs E: Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J 1993, 12:973-986
27. Guo L, Degenstein L, Fuchs E: Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 1996, 10:165-175
28. Danilenko DM, Ring BD, Yanagihara D, Benson W, Wiemann B, Starnes CO, Pierce GF: Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation: normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia. Am J Pathol 1995, 147:145-154
29. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT: Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 1992, 89:6896-6900
30. Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, Williams LT: The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 1994, 266:819-822
31. LaRochelle WJ, Dirsch OR, Finch PW, Cheon HG, May M, Marchese C, Pierce JH, Aaronson SA: Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera. J Cell Biol 1995, 129: 357-366
32. Rapraeger AC, Guimond S, Krufka A, Olwin BB: Regulation by heparan sulfate in fibroblast growth factor signaling. Methods Enzymol 1994, 245:219-240
33. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC: Activating and inhibitory heparin sequences for FGF-2 (basic FGF): distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 1993, 268: 23906-23914
34. Brickman YG, Ford MD, Small DH, Bartlett PF, Nurcombe V: Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells. J Biol Chem 1995, 270:24941-24948
35. Prestrelski SJ, Fox GM, Arakawa T: Binding of heparin to basic fibroblast growth factor induces a conformational change. Arch Biochem Biophys 1992, 293: 314-319
36. Pantoliano MW, Horlick RA, Springer BA, Van Dyk DE, Tobery T, Wetmore DR, Lear JD, Nahapetian AT, Bradley JD, Sisk WP: Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994, 33: 10229-10248
37. Springer BA, Pantoliano MW, Barbera FA, Gunyuzlu PL, Thompson LD, Herblin WF, Rosenfeld SA, Book GW: Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J Biol Chem 1994, 269: 26879-26884
38. Thompson LD, Pantoliano MW, Springer BA: Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry 1994, 33:3831-3840
39. Salmivirta M, Heino J, Jalkanen M: Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth. J Biol Chem 1992, 267:17606-17610
40. Steinfeld R, Vandenberghe H, David G: Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 1996, 133:405-416
41. Chernousov MA, Carey DJ: N-syndecan (syndecan 3) from neonatal rat brain binds basic fibroblast growth factor. J Biol Chem 1993, 268:16810-16814
42. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995, 128:687-698
43. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A: Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994, 79:1005-1013
44. Nurcombe V, Ford MD, Wildschut JA, Bartlett PF: Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 1993, 260:103-106
45. Ford MD, Bartlett PF, Nurcombe V: Co-localization of FGF-2 and a novel heparan sulphate proteoglycan in embryonic mouse brain. Neuroreport 1994, 5:565-568
46. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z: Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 1992, 12:112-127
47. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Vergilio JA, Nicholson AC: Macrophage and foam cell release of matrix-bound growth factors: role of plasminogen activation. J Biol Chem 1993, 268:11951-11958
48. Whitelock JM, Murdoch AD, lozzo RV, Underwood PA: The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 1996, 271:10079-10086
49. Vlodavsky I, Mohsen M, Lider O, Svahn CM, Ekre HP, Vigoda M, Ishai-Michaeli R, Peretz T: Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis 1994, 14:290-302
50. Bitan M, Mohsen M, Levi E, Wygoda MR, Miao HQ, Lider O, Svahn CM, Ekre HP, Ishai-Michaeli R, Bar-Shavit R, Vlodavsky I, Peretz T: Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Isr J Med Sci 1995, 31:106-118
51. Kessler DA, Langer RS, Pless NA, Folkman J: Mast cells and tumor angiogenesis. Int J Cancer 1976, 18: 703-709